Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice.
alcoholic fatty liver disease
lipid droplets
lipidomics
metabolomics
non-alcoholic fatty liver disease
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
19 Jun 2023
19 Jun 2023
Historique:
received:
24
05
2023
revised:
14
06
2023
accepted:
15
06
2023
medline:
29
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
Non-alcoholic steatohepatitis (NASH) and alcoholic steatohepatitis (ASH) are the leading causes of liver disease worldwide. To identify disease-specific pathomechanisms, we analyzed the lipidome, metabolome and immune cell recruitment in livers in both diseases. Mice harboring ASH or NASH had comparable disease severities regarding mortality rate, neurological behavior, expression of fibrosis marker and albumin levels. Lipid droplet size was higher in NASH than ASH and qualitative differences in the lipidome were mainly based on incorporation of diet-specific fatty acids into triglycerides, phosphatidylcholines and lysophosphatidylcholines. Metabolomic analysis showed downregulated nucleoside levels in both models. Here, the corresponding uremic metabolites were only upregulated in NASH suggesting stronger cellular senescence, which was supported by lower antioxidant levels in NASH as compared to ASH. While altered urea cycle metabolites suggest increased nitric oxide synthesis in both models, in ASH, this depended on increased L-homoarginine levels indicating a cardiovascular response mechanism. Interestingly, only in NASH were the levels of tryptophan and its anti-inflammatory metabolite kynurenine upregulated. Fittingly, high-content immunohistochemistry showed a decreased macrophage recruitment and an increased polarization towards M2-like macrophages in NASH. In conclusion, with comparable disease severity in both models, higher lipid storage, oxidative stress and tryptophan/kynurenine levels were seen in NASH, leading to distinct immune responses.
Identifiants
pubmed: 37373497
pii: ijms241210351
doi: 10.3390/ijms241210351
pmc: PMC10299521
pii:
doi:
Substances chimiques
Kynurenine
343-65-7
Tryptophan
8DUH1N11BX
Fatty Acids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : SCHO817/3-3
Organisme : Deutsche Forschungsgemeinschaft
ID : SFB1039 (TP A08)
Organisme : Deutsche Forschungsgemeinschaft
ID : GRK2336 (TP07)
Organisme : LOEWE Centre ACLF-I
ID : P02, Z01
Organisme : Fraunhofer Cluster of Excellence for Immune-Mediated Diseases
ID : CMID
Organisme : Deutsche Forschungsgemeinschaft
ID : 445757098
Organisme : Deutsche Forschungsgemeinschaft
ID : CPI EXC 2026, Project ID: 390649896
Références
Amino Acids. 2015 Sep;47(9):2005-14
pubmed: 25820767
Curr Protein Pept Sci. 2019;20(2):184-193
pubmed: 30370846
Metabolites. 2023 Mar 31;13(4):
pubmed: 37110163
J Biol Chem. 2004 Aug 27;279(35):36192-200
pubmed: 15192091
Lancet Infect Dis. 2003 Oct;3(10):644-52
pubmed: 14522263
Front Immunol. 2021 Feb 12;11:607048
pubmed: 33643293
Cell. 2015 Jul 2;162(1):184-97
pubmed: 26095251
Alcohol Clin Exp Res. 1993 Apr;17(2):268-71
pubmed: 8488966
J Hepatol. 2023 Apr 14;:
pubmed: 37061196
Mol Biosyst. 2010 Apr;6(4):641-7
pubmed: 20237641
Function (Oxf). 2022 Aug 24;3(5):zqac039
pubmed: 36120487
Circulation. 2010 Sep 7;122(10):967-75
pubmed: 20733103
Cells. 2022 May 17;11(10):
pubmed: 35626695
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
Prostaglandins Other Lipid Mediat. 2022 Oct;162:106660
pubmed: 35714920
EMBO Mol Med. 2023 Feb 8;15(2):e16796
pubmed: 36541656
Curr Protoc Neurosci. 2016 Apr 08;75:9.52.1-9.52.16
pubmed: 27063788
Cell Death Differ. 2002 Oct;9(10):1069-77
pubmed: 12232795
Nat Rev Cancer. 2007 Aug;7(8):599-612
pubmed: 17646865
Free Radic Biol Med. 2002 Jan 1;32(1):11-6
pubmed: 11755312
Hepatology. 2012 Jun;55(6):1711-21
pubmed: 22213086
J Physiol. 2022 Apr;600(8):1825-1837
pubmed: 35307840
Gut. 2021 Feb;70(2):388-400
pubmed: 32327527
Int J Mol Sci. 2022 Jan 07;23(2):
pubmed: 35054837
J Exp Med. 2002 Aug 19;196(4):459-68
pubmed: 12186838
Amino Acids. 2015 Sep;47(9):1697-702
pubmed: 26210755
J Invest Dermatol. 2017 Mar;137(3):686-695
pubmed: 27818280
J Lipid Res. 2016 Aug;57(8):1329-38
pubmed: 27146479
J Transl Med. 2018 Dec 7;16(1):344
pubmed: 30526624
PLoS Biol. 2018 Jul 3;16(7):e2005970
pubmed: 29969450
J Mass Spectrom Adv Clin Lab. 2023 Feb 17;28:35-46
pubmed: 36872954
Int J Mol Sci. 2023 Mar 17;24(6):
pubmed: 36982811
Gastroenterology. 2020 May;158(7):1851-1864
pubmed: 32061595
Semin Liver Dis. 2013 Nov;33(4):321-9
pubmed: 24222090
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):50-59
pubmed: 28930290
Am J Pathol. 2012 Mar;180(3):998-1007
pubmed: 22234172
Nat Rev Dis Primers. 2018 Aug 16;4(1):16
pubmed: 30115921
Mol Brain. 2009 Mar 27;2:8
pubmed: 19323847
Fundam Clin Pharmacol. 2023 Jun;37(3):519-529
pubmed: 36509694
Mol Metab. 2022 Dec;66:101617
pubmed: 36270612
Blood. 2006 Apr 1;107(7):2846-54
pubmed: 16339401
Am J Physiol Gastrointest Liver Physiol. 2019 Aug 1;317(2):G182-G194
pubmed: 31188634